Corporate Action

Beyond a simple FDA approval, Amneal's entry into the epinephrine vial market is a calculated move to fix a broken supply chain and drive growth.

Surpassing one trillion interactions, Iterable's AI and new leadership signal a shift where marketing platforms become critical hubs for operational intelligence.

A routine regulatory filing reveals First Trust's 4.99% stake in NCC Group, fueling speculation around the struggling cybersecurity firm's future.

A key advisory appointment reveals a pivotal trend in private equity: a move from deal-making to deep operational focus for maximizing portfolio returns.

Trinity Consultants' acquisition of CEQA/NEPA expert Meridian is more than a regional deal; it's a strategic move with deep implications for biopharma.

A new study reveals a simple dietary change—swapping carb snacks for tree nuts—can curb cravings for junk food and improve health in young adults.

GE Lighting's latest launch isn't just about new bulbs. It's a strategic play balancing sculptural design with scientific precision for the modern home.

Record shareholder approval and robust financials signal strong investor confidence as the gold producer eyes strategic expansion in a bullish market.

The biggest obstacle to the EV revolution might be under your feet. One company's simple, award-winning solution to a muddy problem is changing the game.

The biotech is advancing a promising myelofibrosis therapy while developing a next-gen 'super drug,' a dual strategy signaling significant growth.

A junior miner's savvy strategy to re-examine old drill core could unlock new value, positioning its gold-lithium project at the nexus of today's markets.

The global caterer's share repurchase signals more than financial health; it's a strategic move to fuel growth, reward investors, and reshape its future.

A critical shortage of aircraft mechanics threatens global travel. Now, a trade school's debut on Amazon Prime signals a major shift in valuing skilled careers.

Vermont's WhistlePig isn't just opening a bar in Louisville; it's launching a strategic assault on tradition with an immersive, high-tech whiskey vault.

Echobit's listing of ORIGYN's AI provenance protocol signals a strategic move into digital asset verification, blending blockchain with AI development.

Lexicon's sotagliflozin may revolutionize HFpEF treatment by targeting adipose tissue, a move that could differentiate it in a crowded market.

Parsons Corporation has secured a key position on a $3.5 billion DTRA contract, reaffirming its critical role in global efforts to counter weapons of mass destruction.

In a complex financial market, one firm's new L&D chief isn't just a hire; it's a strategic weapon. Here's why their investment in talent could pay dividends.

The off-price giant is ditching traditional ads for a superfan bus tour. We analyze why this experiential move signals a major shift in retail marketing.

A new partnership between Pellera Technologies and the NY Rangers is more than a sponsorship. It's a strategic play on heritage, B2B marketing, and community.